Feasibility of weekly intraperitoneal versus intravenous paclitaxel therapy delivered from the day of radical surgery for gastric cancer: a preliminary safety analysis of the INPACT study, a randomized controlled trial

The role of HIPEC in the treatment of peritoneal carcinomatosis from gastric cancer

(2015) Maria Di Vita et al.   ANTI-CANCER DRUGS

Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing regimens (JCOG0407)

(2015) Tomohiro Nishina et al.   Gastric Cancer

Staging Laparoscopy for Patients with cM0, Type 4, and Large Type 3 Gastric Cancer

(2015) Yuichiro Miki et al.   WORLD JOURNAL OF SURGERY

A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for stage III/IV gastric cancer (CCOG 1106)

(2014) Keisuke Kurimoto et al.   Gastric Cancer

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Rates and Patterns of Recurrence after Curative Intent Resection for Gastric Cancer: A United States Multi-Institutional Analysis

(2014) Gaya Spolverato et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial

(2014) Akira Tsuburaya et al.   LANCET ONCOLOGY

Treatment and prevention of peritoneal carcinomatosis from gastric cancer by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Overview and rationale

(2013) F. Roviello et al.   EJSO

Phase II study of preoperative chemotherapy with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210)

(2013) Yoshiaki Iwasaki et al.   JOURNAL OF SURGICAL ONCOLOGY

Randomized clinical trial of adjuvant chemotherapy with intraperitoneal and intravenous cisplatin followed by oral fluorouracil (UFT) in serosa-positive gastric cancer versus curative resection alone: final results of the Japan Clinical Oncology Group trial JCOG9206-2

(2011) Isao Miyashiro et al.   Gastric Cancer

Safety of intraperitoneal administration of paclitaxel after gastrectomy with en-bloc D2 Lymph node dissection

(2011) Motohiro Imano et al.   JOURNAL OF SURGICAL ONCOLOGY

A Randomized Phase II Trial to Test the Efficacy of Intra-peritoneal Paclitaxel for Gastric Cancer with High Risk for the Peritoneal Metastasis (INPACT Trial)

(2010) Y. Kodera et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis

(2009) H. Ishigami et al.   ANNALS OF ONCOLOGY

Extensive Intraoperative Peritoneal Lavage as a Standard Prophylactic Strategy for Peritoneal Recurrence in Patients with Gastric Carcinoma

(2009) Masafumi Kuramoto et al.   ANNALS OF SURGERY

A phase II study of radical surgery followed by postoperative chemotherapy with S-1 for gastric carcinoma with free cancer cells in the peritoneal cavity (CCOG0301 study)

(2009) Y. Kodera et al.   EJSO

Phase I Pharmacokinetic Study of Weekly Intravenous and Intraperitoneal Paclitaxel Combined with S-1 for Advanced Gastric Cancer

(2009) Hironori Ishigami et al.   ONCOLOGY

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

(2008) Wasaburo Koizumi et al.   LANCET ONCOLOGY